REGN Earnings Regeneron Pharmaceuticals
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 6.75 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 41.48 | 2026-02-04 | 10-K |
| Q3 2025 | 2025-09-30 | 33.61 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | 20.02 | 2025-08-01 | 10-Q |
| Q1 2026 | 2025-03-31 | 7.27 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | 38.34 | 2026-02-04 | 10-K |
| Q3 2025 | 2024-09-30 | 30.23 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | 18.68 | 2025-08-01 | 10-Q |
| Q1 2025 | 2024-03-31 | 6.27 | 2025-04-29 | 10-Q |
| FY 2025 | 2023-12-31 | 34.77 | 2026-02-04 | 10-K |
| Q3 2024 | 2023-09-30 | 24.57 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | 15.68 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 7.17 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | 38.22 | 2025-02-05 | 10-K |
| Q3 2023 | 2022-09-30 | 27.73 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | 16.07 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | 8.61 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | 71.97 | 2024-02-05 | 10-K |
| Q3 2022 | 2021-09-30 | 52.29 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 38.07 | 2022-08-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.